Bilikere S Dwarakanath Selected Research

Bilikere S Dwarakanath Research Topics

Disease

29	Neoplasms (Cancer) 01/2023 - 08/2005
6	Glioma (Gliomas) 01/2023 - 04/2010
4	Inflammation (Inflammations) 01/2023 - 01/2018
3	Pneumonia (Pneumonitis) 06/2022 - 01/2018
2	Fibrosis (Cirrhosis) 06/2022 - 01/2018
2	Neoplasm Metastasis (Metastasis) 12/2019 - 01/2015
2	Neuroblastoma 01/2018 - 01/2018
2	Carcinogenesis 05/2015 - 01/2015
2	Carcinoma (Carcinomatosis) 01/2015 - 10/2013
1	Endotoxemia 01/2023
1	Thoracic Neoplasms 06/2022
1	COVID-19 11/2020
1	Cytokine Release Syndrome 11/2020
1	Acute Radiation Syndrome 10/2019
1	Lung Injury 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Leishmaniasis 01/2015
1	Infections 01/2015
1	Visceral Leishmaniasis (Kala Azar) 01/2015
1	Hypoxia (Hypoxemia) 01/2015
1	Ascites 01/2015
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2015
1	Body Weight (Weight, Body) 01/2012
1	Radiation Injuries (Radiation Sickness) 01/2012
1	Wounds and Injuries (Trauma) 01/2012

Drug/Important Bio-Agent (IBA)

7	Deoxyglucose (2 Deoxy D glucose)IBA 01/2023 - 08/2005
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2011
3	CalreticulinIBA 12/2022 - 03/2011
3	Acetates (Acetic Acid Esters)FDA Link 12/2022 - 01/2014
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018 - 01/2018
2	CarbonIBA 01/2023 - 10/2022
2	LigandsIBA 01/2023 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 08/2005
2	Amifostine (Ethyol)FDA LinkGeneric 06/2022 - 01/2018
2	CytokinesIBA 01/2018 - 01/2015
2	AntioxidantsIBA 01/2018 - 05/2011
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2015 - 01/2015
2	aluminum phthalocyanine disulfonateIBA 07/2011 - 04/2010
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2023
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2023
1	HexokinaseIBA 01/2023
1	Pyruvate KinaseIBA 01/2023
1	Nucleic AcidsIBA 01/2023
1	Notch ReceptorsIBA 10/2022
1	CollagenIBA 06/2022
1	Hydroxyproline (4 Hydroxyproline)IBA 06/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Viral ProteinsIBA 11/2020
1	Protons (Proton)IBA 03/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019
1	ElementsIBA 10/2019
1	Histone Deacetylase InhibitorsIBA 02/2018
1	CaspasesIBA 01/2018
1	resolvin D1IBA 01/2018
1	protectin D1IBA 01/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018
1	Arachidonic Acid (Vitamin F)IBA 01/2018
1	EicosanoidsIBA 01/2018
1	lipoxin A4IBA 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	LipidsIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	AcidsIBA 05/2015
1	anthraceneIBA 05/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2015
1	Interleukin-2 (IL2)IBA 05/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2015
1	Adenosine Triphosphate (ATP)IBA 05/2015
1	VaccinesIBA 01/2015
1	Drinking WaterIBA 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	InflammasomesIBA 01/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2015
1	Bromodeoxyuridine (BrdU)IBA 01/2015
1	IntegrinsIBA 01/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015
1	Pattern Recognition ReceptorsIBA 01/2015
1	Metalloproteases (Metalloproteinases)IBA 01/2015
1	Blood Glucose (Blood Sugar)IBA 01/2015
1	coumarinIBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 10/2013
1	Proline (L-Proline)FDA Link 10/2013
1	allyl sulfideIBA 01/2012
1	Radiation-Protective Agents (Radiation Protectants)IBA 01/2012
1	amsonic acid (DAS)IBA 01/2012
1	CalciumIBA 12/2011
1	Liposomes (Liposome)IBA 07/2011

Therapy/Procedure

15	Therapeutics 01/2023 - 05/2010
9	Radiotherapy 10/2022 - 08/2005
4	Drug Therapy (Chemotherapy) 01/2020 - 03/2011
3	Immunotherapy 01/2019 - 01/2018
1	Heavy Ion Radiotherapy 10/2022
1	Conformal Radiotherapy 01/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022
1	Image-Guided Radiotherapy 01/2022
1	Adjuvant Chemotherapy 01/2018
1	Topical Administration 05/2015
1	Immunomodulation 01/2015